Report copyright - A Phase 2 Study to Assess the Safety and Efficacy of ... iwCLL 2019 Umbralisib TKI Intolerant.pdf · 1 case of colitis reported after 6 weeks on treatment –17p del CLL patient
Please pass captcha verification before submit form
Please pass captcha verification before submit form